NCT04665960View on ClinicalTrials.gov

Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2

CompletedOBSERVATIONAL
Enrollment

35

Participants

Timeline

Start Date

March 29, 2021

Primary Completion Date

April 25, 2021

Study Completion Date

May 1, 2021

Conditions
Covid19SARS-CoV InfectionSARS PneumoniaCoronavirus InfectionInfection
Trial Locations (1)

7832

NMC Specialty Hospital, Dubai

All Listed Sponsors
lead

NMC Specialty Hospital

OTHER

NCT04665960 - Infection Control for Severe Acute Respiratory Syndrome Coronavirus 2 | Biotech Hunter | Biotech Hunter